Liquid biopsy: the missing piece

Dr. Ioannis Papasotiriou MD, PhD, SCym is giving answers to crucial questions.
The ease of testing is not the only reason for using liquid biopsies over tissue biopsies.
The fact is that while tissue biopsies provide information from a single sampling site, they can't offer insights into distant sites, like metastases or lymph node involvement.
Liquid biopsies complement this by providing missing information. Combining data from both types of biopsies gives a complete picture of a patient's health profile.
RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou who believes that the key to effectively treating cancer lies in personalized medicine using the information in a patient’s genes.
Individualized treatment for cancer is the focus behind RGCC’s testing protocols and advanced therapy options. Our slate of tests analyzes the state of a person’s cancer by looking at the cellular and genetic makeup of each patient. Our test results give you information that acts as a blueprint for what treatment protocols are likely to show the most efficacy for your specific biology.
Learn more about RGCC at
rgcc-internati...
myrgcc.com/
Follow us on social media to find out the latest news and updates from our experts.
Facebook:
/ rgcc.international
www.facebook.c...
Instagram:
/ research_genetic_cance...
/ rgcc_north_america
LinkedIn: / r-g-c-c-international-...